Tirzepatide vs BPC-157
A comprehensive, data-driven comparison of Tirzepatide (Mounjaro) and BPC-157 (Body Protection Compound-157). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Tirzepatide Mounjaro, Zepbound | BPC-157 Body Protection Compound-157, PL 14736 |
|---|---|---|
| FDA Status | FDA Approved | Category 2 (pending reclassification) |
| Category | Weight Loss | Recovery & Healing |
| Primary Use | Type 2 diabetes, chronic weight management, and obstructive sleep apnea | Tissue healing and injury recovery |
| Weight Loss % | 22.5% | N/A |
| Monthly Cost | $1,100 - $1,100/mo | $50 - $120/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 15mg weekly (max dose) | 250-500mcg daily |
| Frequency | Weekly | Daily |
| Mechanism | Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric emptying, and decreases appetite | Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth factors, and accelerates tissue repair |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Low |
| Clinical Trial Phase | Approved | N/A |
Key Differences
- 1Tirzepatide is FDA-approved, while BPC-157 is currently category 2 (pending reclassification).
- 2Tirzepatide has clinical weight loss data (22.5%), while BPC-157 is not primarily indicated for weight loss.
- 3BPC-157 is generally more affordable ($50 - $120/mo) compared to Tirzepatide ($1,100 - $1,100/mo).
- 4Tirzepatide is dosed weekly, while BPC-157 is daily.
- 5Tirzepatide has high-quality evidence, while BPC-157 has low-quality evidence.
- 6They belong to different categories: Tirzepatide (Weight Loss) vs BPC-157 (Recovery & Healing).
Which Is Better For...
Tirzepatide
Those seeking an FDA-approved treatment with established safety data
BPC-157
More budget-friendly option with lower monthly costs
Tirzepatide
More convenient dosing schedule (weekly)
BPC-157
Fewer commonly reported side effects
Tirzepatide
Stronger clinical evidence base to support its use
Get Tirzepatide or BPC-157 Online
Vetted telehealth providers that prescribe either peptide.
PeptideVS may earn a commission from providers listed below. Our editorial data is independent - see our disclosure for details.
Henry Meds
Sponsored
Compounded GLP-1 therapy with flat monthly pricing and no insurance hassle.
- Flat monthly price, no insurance required
- Compounded semaglutide and tirzepatide
- Licensed providers in 50 states
We may earn a commission when you sign up.
Mochi Health
Sponsored
Obesity-medicine-trained clinicians and a care team built around women.
- Obesity-medicine-trained MDs and RDs
- Compounded and brand-name GLP-1 options
- Insurance-aware pricing and savings tools
We may earn a commission when you sign up.
Found Health
Sponsored
Weight-care program combining GLP-1s with behavior coaching and nutritionists.
- Whole-person program, not just a prescription
- Insurance-first with cash-pay fallback
- Nutrition and habit coaching included
We may earn a commission when you sign up.
Ro Body
Sponsored
Brand-name Wegovy and Zepbound plus compounded options, handled end to end.
- Brand-name and compounded GLP-1 paths
- Insurance navigation built into intake
- Nationwide telehealth with ongoing check-ins
We may earn a commission when you sign up.
Hers Weight
Sponsored
GLP-1 injections paired with behavior coaching for long-term weight care.
- Compounded GLP-1 with licensed providers
- Coaching and habit support in-app
- Transparent monthly pricing
We may earn a commission when you sign up.
PlushCare
Sponsored
Primary-care telehealth with broad Rx coverage and same-day appointments.
- Broad primary-care scope, not GLP-1-only
- Same-day video visits in all 50 states
- Works with insurance for most plans
We may earn a commission when you sign up.
Eden
Sponsored
Research peptide telehealth covering recovery, longevity, and growth-hormone protocols.
- Non-GLP-1 peptide catalog (GHRH, healing, longevity)
- Licensed prescriber intake, US pharmacy fulfillment
- Multi-peptide stacks available
We may earn a commission when you sign up.
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Tirzepatide | $1,100 - $1,100/mo | FDA Approved | Eli Lilly |
| BPC-157 | $50 - $120/mo | Category 2 (pending reclassification) | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Tirzepatide works via Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric. BPC-157 works via Synthetic peptide derived from gastric juice protein that promotes angiogenesis, modulates growth. They differ in FDA approval status, efficacy data, and cost.
Tirzepatide has demonstrated 22.5% average weight loss in clinical trials. BPC-157 is not primarily used for weight loss.
Tirzepatide typically costs $1,100 - $1,100/mo, while BPC-157 costs $50 - $120/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Tirzepatide is FDA-approved. BPC-157 is not FDA-approved (Category 2 (pending reclassification)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Tirzepatide include Nausea, Diarrhea, Decreased appetite. Common side effects of BPC-157 include Injection site discomfort, Mild headache, Dizziness. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Tirzepatide is a dual-action peptide approved by the FDA as Mounjaro for type 2 diabetes and Zepbound for weight management. In December 2024, Zepbound became the first and only medication approved fo...
View Full Tirzepatide GuideBPC-157 is a synthetic peptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. Although not FDA-approved, it has gained significant attention in research a...
View Full BPC-157 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tirzepatide and BPC-157 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.